Skin-Resident Antigen-Presenting Cells: Instruction Manual for Vaccine Development
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 55362
- https://doi.org/10.3389/fimmu.2013.00157
Abstract
The induction of antigen-specific effector T cells is driven by proper antigen presentation and co-stimulation by dendritic cells (DCs). For this reason strategies have been developed to instruct DCs for the induction of CD4+ and CD8+ T cell responses. Since DCs are localized, amongst other locations, in peripheral tissues such as the skin, new vaccines are aiming at targeting antigens to DCs in situ. Optimal skin-DC targeting in combination with adequate adjuvant delivery facilitates DC maturation and migration to draining lymph nodes and enhances antigen cross-presentation and T cell priming. In this review we describe what DC subsets populate the human skin, as well as current vaccination strategies based on targeting strategies and alternative administration for the induction of robust long-lived anti-cancer effector T cells.Keywords
This publication has 54 references indexed in Scilit:
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic CellsImmunity, 2012
- Adjuvants for human vaccinesCurrent Opinion in Immunology, 2012
- Characterization of resident and migratory dendritic cells in human lymph nodesThe Journal of Experimental Medicine, 2012
- How Tolerogenic Dendritic Cells Induce Regulatory T CellsPublished by Elsevier ,2010
- Dissolving polymer microneedle patches for influenza vaccinationNature Medicine, 2010
- Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cellsThe Journal of Experimental Medicine, 2010
- Understanding human myeloid dendritic cell subsets for the rational design of novel vaccinesHuman Immunology, 2009
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9Journal of Investigative Dermatology, 2007